Precipio Price to Sales Ratio 2010-2025 | PRPO

Historical PS ratio values for Precipio (PRPO) over the last 10 years. The current P/S ratio for Precipio as of June 18, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Precipio P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-06-18 10.85 0.80
2025-03-31 6.27 $13.55 0.46
2024-12-31 5.54 $12.68 0.44
2024-09-30 6.70 $12.30 0.54
2024-06-30 5.19 $12.02 0.43
2024-03-31 6.70 $11.89 0.56
2023-12-31 6.50 $11.90 0.55
2023-09-30 5.61 $10.67 0.53
2023-06-30 7.80 $9.38 0.83
2023-03-31 13.28 $8.55 1.55
2022-12-31 11.03 $8.28 1.33
2022-09-30 16.08 $8.49 1.89
2022-06-30 21.20 $8.52 2.49
2022-03-31 27.00 $8.67 3.11
2021-12-31 31.60 $8.56 3.69
2021-09-30 56.40 $8.60 6.56
2021-06-30 72.60 $8.66 8.38
2021-03-31 46.20 $8.73 5.29
2020-12-31 41.40 $9.60 4.31
2020-09-30 49.00 $9.66 5.07
2020-06-30 28.40 $10.16 2.80
2020-03-31 14.00 $11.19 1.25
2019-12-31 41.00 $12.42 3.30
2019-09-30 52.20 $19.51 2.68
2019-06-30 67.60 $25.37 2.66
2019-03-31 37.50 $33.85 1.11
2018-12-31 46.20 $46.70 0.99
2018-09-30 118.56 $98.16 1.21
2018-06-30 110.34 $100.65 1.10
2018-03-31 161.16 $225.69 0.71
2017-12-31 360.00 $374.03 0.96
2017-09-30 648.00 $754.49 0.86
2017-06-30 2700.00 $986.94 2.74
2017-03-31 5057.49 $1,210.10 4.18
2016-12-31 2557.54 $1,147.37 2.23
2016-09-30 2537.75 $996.66 2.55
2016-06-30 4949.50 $973.32 5.09
2016-03-31 5251.87 $953.32 5.51
2015-12-31 9629.04 $1,600.71 6.02
2015-09-30 8307.97 $-18,488.75 0.00
2015-06-30 15028.50 $-13,628.75 0.00
2015-03-31 12958.70 $-5,513.75 0.00
2014-12-31 18088.20 $1,550.00 11.67
2014-09-30 33926.60 $29,121.25 1.17
2014-06-30 33656.60 $32,348.75 1.04
2014-03-31 41215.90 $33,026.25 1.25
2013-12-31 49133.10 $34,430.00 1.43
2013-09-30 41034.30 $38,810.83 1.06
2013-06-30 43194.00 $30,503.44 1.42
2013-03-31 42654.00 $21,371.07 2.00
2012-12-31 65870.80 $12,153.69 5.42
2012-09-30 102586.00 $17,142.35 5.98
2012-06-30 97186.40 $17,142.41 5.67
2012-03-31 129582.00 $17,142.44 7.56
2011-12-31 139300.00 $17,142.47 8.13
2011-09-30 139300.00 $0.58 241013.88
2011-06-30 188974.00 $0.50 377706.68
2011-03-31 95026.70 $0.45 211949.24
2010-12-31 71270.00 $0.41 175010.35
2010-09-30 43194.00 $0.44 99006.31
2010-06-30 52912.60 $0.45 117791.92
2010-03-31 92435.10 $0.46 202299.46
2009-12-31 74509.60 $0.45 166422.70
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.017B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.064B 58.60
Hims & Hers Health (HIMS) United States $13.260B 137.77
Tempus AI (TEM) United States $12.137B 0.00
IRhythm Technologies (IRTC) United States $4.628B 0.00
Inspire Medical Systems (INSP) United States $3.753B 58.64
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.730B 186.58
Enovis (ENOV) United States $1.764B 9.83
Schrodinger (SDGR) United States $1.532B 0.00
Phreesia (PHR) United States $1.519B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.342B 62.36
Omnicell (OMCL) United States $1.335B 23.55
10x Genomics (TXG) United States $1.300B 0.00
Claritev (CTEV) United States $0.661B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Butterfly Network (BFLY) United States $0.544B 0.00
Talkspace (TALK) United States $0.477B 142.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.348B 771.33
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
American Well (AMWL) United States $0.104B 0.00
CareCloud (CCLD) United States $0.099B 3.79
MDxHealth SA (MDXH) Belgium $0.093B 0.00
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00